Zimbabwe Approves Use of Injectable HIV Prevention DrugBy Babatunde OguntimehinOctober 20, 2022 The Medicines Control Authority of Zimbabwe has announced the approval of the use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) for HIV prevention,…